Showing results (121-130 of 276) with videos related to
Sort By:
Pageof 28
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.Gynecologic Oncology|June 15, 2017
The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgeryChristoph Grimm, Philipp Harter, Pier F Alesina, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2024
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay PerformanceMarcel Romey, Fiona Rodepeter, Akira Hattesohl, et al.Annals of Surgical Oncology|October 12, 2012
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluationChristina Fotopoulou, Rongyu Zang, Murat Gultekin, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 10, 2024
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trialRobert L Coleman, Domenica Lorusso, Ana Oaknin, et al.British Journal of Cancer|November 9, 2016
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancerJonathan A Ledermann, Philipp Harter, Charlie Gourley, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-MitteIrina Tsibulak, Rozita Hashemi, Julia Welz, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcomaDominique Berton-Rigaud, Mojgan Devouassoux-Shisheboran, Jonathan A Ledermann, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2020
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)Philipp Harter, Patricia Pautier, Els Van Nieuwenhuysen, et al.International Journal of Cancer|April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortiumEva Obermayr, Thomas Mohr, Eva Schuster, et al.Pageof 28